PhytoMedical Technologies, Inc. (PYTO.OB) Partners with Renowned Specialty Laboratory Latitude Pharmaceuticals Inc. to Develop an IV Formulation for Its Successfully Tested Anti-Cancer Compound for Glioblastoma
8/5/2009 9:02:42 AM
More...
|
PhytoMedical Technologies, Inc. (PYTO.OB)'s Anti-Cancer Compound Development Advancing After a Series of Highly Favorable Test Results
6/16/2009 9:56:39 AM
More...
|
A Senior Cancer Researcher Joins PhytoMedical Technologies, Inc. (PYTO.OB) on Heels of Company’s Successful Preclinical Study on Human Brain Cancer
2/26/2009 9:19:35 AM
More...
|
PhytoMedical Technologies, Inc. (PYTO.OB)’s Patented Anti-Cancer Compound Eradicates Tumor in Successful In-Vivo Tests against Human Brain Cancer
2/3/2009 10:11:53 AM
More...
|
PhytoMedical Technologies, Inc. (PYTO.OB)’s In Vivo Toxicity and Efficacy Tests on Human Colon Cancer Deliver Promising Results
10/27/2008 10:06:25 AM
More...
|
PhytoMedical Technologies, Inc. (PYTO.OB) Renews Sponsored Research Agreement with Dartmouth College
10/6/2008 8:39:28 AM
More...
|
PhytoMedical Technologies, Inc. (PYTO.OB) Expands Anti-Cancer Research with Important Efficacy Tests
4/14/2008 9:39:33 AM
More...
|
PhytoMedical Technologies, Inc. (PYTO.OB) Advances Research of Patented Anti-Cancer Compound with Important Toxicity Tests
3/17/2008 10:35:44 AM
More...
|
PhytoMedical Technologies, Inc. (PYTO.OB)'s Latest Anti-Cancer Compounds Kill Human Colon Cancer Cells
3/3/2008 9:03:25 AM
More...
|
PhytoMedical Technologies, Inc. (PYTO.OB) Bolsters Cancer Research Following Favorable Results
2/4/2008 9:23:02 AM
More...
|
|